Blog - INTERNET MÉDICA

■ A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumors

Matthew R Russell, Ciaren Graham, Alfonsina D’Amato et al

Br J Cancer. 2017 Aug 22; 117(5): 666–674

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572165/

■ Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistancetotaxanes in ovarian câncer cells and are associated with epithelil-to-mesenchymal transition

George E Duran, Yan C Wang, François Moisan, E Brian Francisco, Branimir I Sikic

Br J Cancer. 2017 May 9; 116(10): 1318–1328

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482726/

■ The role of endocrine G protein-coupled receptors in ovarian cancer progression

Qingyu Zhang, Nadine Ellen Madden, Alice Sze Tsai Wong, Billy Kwok Chong Chow, Leo TszOn Lee

Front Endocrinol (Lausanne) 2017; 8: 66.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383648/

■ Acute Abdomen Secondary to Ruptured Epithelial Ovarian Cancer during Pregnancy: The Relevance of Teamwork

Ortiz-Mendoza, Carlos Manuel et al

Rev. Bras. Ginecol. Obstet., Sept 2017, vol.39, no.9, p.513-515

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032017000900513&lng=pt&nrm=iso&tlng=en

■ The cost-effectiveness of screening for ovarian cancer, results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Usha Menon, Alistair J McGuire, Maria Raikou et al

Br J Cancer.2017, vol117(5): 619–627

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572177/

■ Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer

Madhumita Chatterjee, Laura C. Hurley, Michael A. Tainsky

GynecolOncol Rep.2017, vol21: 37–44

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476453/

■ Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

TusharTomar, Nicolette G. Alkema, Leroy Schreuder et al

BMC Med.2017; vol15: 116.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481993/

■ Resolution of diffuse intrahepatic biliary strictures after chemotherapy for metastatic ovarian cancer

Daniel Lew, Vinay Sundaram, Brad D. Barrows, Simon K. Lo, Srinivas Gadda

ACG Case Rep J.2017; vol4: e77

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464395/

■ Ovarian needle aspirationg in the diagnosis and management of ovarian masses

Kimberly Nagamine, Jordan Kondo, Ricky Kaneshiro et al

J Gynecol Oncol.2017, vol28(4): e40

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447143/

■ Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer

NienkeZwakman, Rafli van de Laar, Toon Van Gorp et al

J GynecolOncol.2017, vol 28(1): e7.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165075/

■ Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelian ovarian, tubal, or peritoneal carcinoma: a propensity score-matched analysis of 112 consecutive patients

Akimasa Takahashi, Kazuyoshi Kato, Motoki Matsuura et al

Medicine (Baltimore) 2017, vol96(37): e8006

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604650/

■ Skin metastases in ovarian clear cell adenocarcinoma: a case report and a review of the literature

Nam G, Lim YM, Cho MS, Lee J, Kim YH.

ObstetGynecol Sci. 2017 Nov;60(6):593-5

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571707/

■ Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

DimitriosNasioudis, Eloise Chapman-Davis, Melissa K. Freyet al

J Gynecol Oncol.2017, vol28(6): e71

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641522/

■ Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates

LimorHelpman, OmriZidan, Eitan Friedman et al

J Gynecol Oncol.2017 Sep; 28(5): e61

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540720/

■ A multiplex platform for the identification of ovarian cancer biomarkers

Kristin L. M. Boylan, Kate Geschwind, Joseph S. Koopmeiners et al

Clin Proteomics. 2017; vol14: 34

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634875/

■ Ovarian cancer: density equalizing mappingof the global research architecture

DörtheBrüggmann, Katharina Pulch, Doris Klingelhöfer et al

Int J Health Geogr.2017; vol16: 3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237222/

■ Hipercalcemia e hipofosforemiaenniñacon tumor ovárico.

UbetagoyenaArrieta, Mercedes et al.

Nefrología (Madr.), Feb 2017, vol.37, no.1, p.100-101

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952017000100100&lng=en&nrm=iso

■ Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma

Rosie T. Jiang, Anna Yemelyanova, Deyin Xing et al

J Ovarian Res. 2017; 10: 53.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547474/

■ A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass

Santosh Kumar Dora, Atal Bihari Dandapat, Benudhar Pande, Jatindra Prasad Hota

J Ovarian Res. 2017; 10: 55.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556625/

■ Biological effects of combined resveratrol and vitamin D3 on ovarian tissue

Francesca Uberti, Vera Morsanuto, Silvio Aprile et AL

J Ovarian Res. 2017; 10: 61

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602920/

■ Increased`RHAMM expression relates to ovarian cancer progression

Stephanie T. Buttermore, Mitchel S. Hoffman, Ambuj Kumar et al

J Ovarian Res. 2017; 10: 66

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618727/

■ Prediction of clinical response to drugs in ovarian câncer using the chemotherapy resistance test (CTR-test)

Frank Christian Kischkel, Carina Meyer, Julia Eich et al

J Ovarian Res. 2017; 10: 72.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658930/

■ Ovarian mature cystic teratoma: challenges of surgical management

Abha Sinha, Ayman A. A. Ewies

Obstet Gynecol Int. 2016; 2016: 2390178

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823513/

■ Targeting the tumor microenvironment in ovarian cancer

Jean M. Hansen, Robert L. Coleman, Anil K. Sood

Eur J Cancer. 2016, vol 56: 131–143

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769921/

■ Ultrasound monitoring of extant adnexal masses in the era of type 1 and type 2 ovarian cancer: lessons learned from ovarian cancer screening trials

Eleanor L. Ormsby, Edward J. Pavlik, John P. McGahan

Diagnostics (Basel) 2016, vol7(2): 25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489945/

■ Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer

Catherine M. Phelan, Karoline B. Kuchenbaecker et al

Nat Genet.2017, vol49(5): 680–691.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612337/

■ The unique molecular and cellular microenvironment of ovarian cancer

Thomas Worzfeld, ElkePogge von Strandmann, Magdalena Huber et al

Front Oncol.2017;vol7: 24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319992/

■ Management of relapsed ovarian cancer: a review

G H Giomelli

Springerplus 2016, vol 5 (1): 1197

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963348/

■ Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: a review

Eric R. Craig, Angelina I. Londoño, Lyse A. Norian, Rebecca C. Arend

GynecolOncol. 2016 Dec; 143(3): 674–683

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689410/

■ Mechanisms and target involved in dissemination of ovarian cancer

U H Weidle, F Birzele, G Kollmorgen, R Rueger

CancerGenomics Proteomics.2016 Nov-Dec; 13(6): 407–423.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219915/

■ Ovarian cancer screening and mortality in the UK Collaborative Trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial

I J Jacobs, U Menon, A Ryan et al

Lancet 2016, vol 387 (10022): 945-956

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779792/

■ Ovarian cancer screening and mortality in the UK Collaborative Trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial

I J Jacobs, U Menon, A Ryan et al

Lancet 2016, vol 387 (10022): 945-956

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779792/

■ The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patient with ovarian cancer

Emmanouil V. Dermitzakis, Vasilios K. Kimiskidis, George Lazaridis et al

BMC Neurol.2016; vol16: 19

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045633/

■ Racial/ethnic differences affecting adherence to cancer screening guidelines among women

Jacqueline M. Hirth, TabassumHaque Laz, Mahbubur Rahman, Abbey B. Berenson

J Womens Health (Larchmt) 2016, vol25(4): 371–380

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505474/

■ Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment

Veronica Rojas, Kim M. Hirshfield, ShridarGanesan, Lorna Rodriguez-Rodriguez

Int J Mol Sci.2016, vol17(12): 2113

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187913/

■ Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide

Laura B. Huffman, Ellen M. Hartenbach, Jeanne Carter et al

GynecolOncol. 2016, vol140(2): 359–368

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835814/

■ How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer

Sharon L. Bober, Jennifer B. Reese, Lisa Barbera et al

CurrOpin Support Palliat Care. 2016 Mar; 10(1): 44–54.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984532/

■ Adherence of primary care physician to evidence-based recommendations to reduce ovarian cancer mortality

Sherri L. Stewart, Julie S. Townsend, Mary C. Puckett, Sun Hee Rim

J Womens Health (Larchmt). 2016, vol25(3): 235–241.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289707/

■ Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options

Francesco Cosentino, Luigi Carlo Turco, Stefano Cianciet al

J Prenat Med.2016, vol10(1-2): 8–14

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505474/

■ Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2014-to 2011

Sagar C. Patel, Jonathan Frandsen, Sudershan Bhatia, David Gaffney

J GynecolOncol.2016, vol27(5): e45

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944012/

■ Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian fallopian tube, and primary peritoneal cancers

Jovana Y. Martin, Renata R. Urban, John B. Liao, Barbara A. Goff

J GynecolOncol.2016, vol 27(5): e47.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944014/

■ Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer

Tiffany Lai, Bruce Kessel, Hyeong Jun Ahn, Keith Y. Terada

J GynecolOncol.2016 Jul; vol27(4): e41

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864517/

■ Differences in risk for type 1 and type 2 ovarian câncer in a large câncer screening trial

Keith Y. Terada, Hyeong Jun Ahn, Bruce Kessel

J GynecolOncol.2016 May; 27(3): e25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823356/

■ Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

Brittney S Harrington, Yaowu He, Claire M Davies et al

Br J Cancer.2016, vol114(4): 417–426

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815773/

■ Adult body mass index and risk of ovarian cancer subtype: a Mendelian randomization study

Suzanne C Dixon, Christina M Nagle, Aaron P Thrift et al

on behalf of the Ovarian CancerAssociation Consortium,

AOCS Group & Australian CancerStudy (Ovarian Cancer)

Int J Epidemiol.2016 Jun; vol45(3): 884–895

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644573/

■ Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

Katrijn L M Michielsen, IgnaceVergote, RaphaëlaDresen et al

Br J Radiol. November 2016; 89(1067): 2016046

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124845/

■ Analgesic medications use and risk of epithelial ovarian cancer in African American women

Lauren C Peres, Fabian Camacho, Sarah E Abbott et al

Br J Cancer. 2016 Mar 29; 114(7): 819–825

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984862/

■ Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

Jue-Sheng Ong, Gabriel Cuellar-Partida, Yi Lu et al

Australian Ovarian Cancer Study

Int J Epidemiol. 2016 Oct; vol45(5): 1619–1630

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100621/

■ Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report

Sampaio, Joana et al.

Rev. Bras. Ginecol. Obstet., July 2016, vol.38, no.7, p.365-367

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032016000700365&lng=pt&nrm=iso

■ SIADH secundario a adenocarcinoma seroso de ovario tratado conTolvaptán

Araujo Castro, Marta et al.

Rev. chil. obstet. ginecol.,Dic 2016, vol.81, no.6, p.507-510

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262016000600009&lng=en&nrm=iso

■ Tuberculosis peritoneal conpresentación clínica como cáncer ovárico avanzado: revisión de la literatura

Serman V, Felipe et al.

Rev. chil. obstet. ginecol., 2016, vol.81, no.5, p.411-42

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262016000500011&lng=en&nrm=iso

■ Dolor abdominal agudo como presentación de un linfoma ovárico.

LafallaBernad, Olivia et al.

Rev. chil. obstet. ginecol., 2016, vol.81, no.5, p.399-405.

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262016000500009&lng=en&nrm=iso

■ United Kingdom Collaborative Trial of Ovarian Cancer Screening

U Menon, A Ryan, J Kalsi et al

Journal of Clinical Oncology jun 2015

http://ascopubs.org/doi/full/10.1200/JCO.2014.59.4945

■ Asociación entre obesidad y cáncer de ovário

Valladares, Macarena, Corsini, Gino and Romero, Carmen

Rev. méd. Chile, Mayo 2014, vol.142, no.5, p.593-59

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000500007

■ Risk assessment, genetic counseling and genetic testing for BRCA-related cancer in women

S. Preventive Services Task Force Recommendation Statement

V A Moyer

Ann Intern Med 2014, vol 160 (4): 271-281

http://annals.org/aim/fullarticle/1791499/risk-assessment-genetic-counseling-genetic-testing-brca-related-cancer-women

■ Screening for ovarian cancer

S. Preventive Services Task Force Recommendation Statement

V A Moyer

Ann Intern Med 2012, vol 157 (12): 900-904

http://annals.org/aim/fullarticle/1357339/screening-ovarian-cancer-u-s-preventive-services-task-force-reaffirmation

■ Manejo multidisciplinar delcáncer epitelial de ovario: Diagnóstico radiológico.

Sánchez, M.C., Sáenz, J. andOstiz, S.

AnalesSis San Navarra, Ago 2011, vol.34, no.2, p.275-28

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272011000200013&lng=en&nrm=iso

■ byDr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306/40204020

CRMMG: 7026

Email: pfleite1873@gmail.com

Câncer de Pele Online (Skin cancer)

Por Paulo Leite 04/12/2017

■ Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

Mariah M Johnson, Sancy A Leachman, Lisa G Aspinwall et al

Melanoma Manag. 2017, vol 4(1): 13–37

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480135/

■ Skin cancer epidemics in the elderly as emerging issue in geriatric oncology

Simone Garcovich, Giuseppe Colloca, Pietro Sollena et al

Aging Dis. 2017, vol 8(5): 643–661

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614327

■ Carcinoma espinocelular cutaneo invasivo de alto riesgo: uso de clasificaciones actuales

Vasquez, M et al.

Rev. argent. dermatol., Set 2017, vol.98, no.3, p.0-0.

http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2017000300002&lng=es&nrm=iso

■ Seven non-melanoma features to rule out facial melanoma

P Tschandl, A Gambardella, A Boespflug et al

Acta Dermato Venereologica 2017, vol 97 (10)

https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2759

■ Clinical manifestation and pathogenesis of cutaneous lymphomas: current status and future direction

B Rubio-Gonzalez, J Zain, S T Rosen, C Querfeld

British Journal of Haematology 2017, vol 176 (1): 16-36

http://onlinelibrary.wiley.com/doi/10.1111/bjh.14402/full

■ Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches

Zoe Apalla, Dorothée Nashan, Richard B. Weller, Xavier Castellsagué

Dermatol Ther (Heidelb) 2017,vol 7(Suppl 1): 5–19

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289116/

■ Skin cancer concerns particular to women

Al-Dujaili, M. Henry, A.S. Dorizas, N.S. Sadick

Int J Womens Dermatol. 2017 , vol 3(1 Suppl): S49–S51

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419056/

■ Neuroendocrine factors: the missing link in non-melanoma skin cancer

Mihai Lupu, Ana Caruntu, Constantin Caruntu et AL

Oncol Rep. 2017 Sep; 38(3): 1327–1340

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549028/

■ General practitioner management related to sin câncer prevention and screening during standart medical encounteres: a French cross-sectional study based on the International Classification of Primary Care

Cédric Rat, Sara Houd, Aurélie Gaultier, Charlotte Grimault et al

BMJ Open. 2017; vol 7(1): e013033

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293869/

■ Epidemiological trends in skin cancer

Zoe Apalla, Aimilios Lallas, Elena Sotiriou et al

Dermatol Pract Concept. 2017, vol 7(2): 1–6.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424654/

■ Dermoscopic findings in na early malignant fibrous histiocytoma on the face

Gabriel Salerni, Carlos Alonso, German Sanchez-Granel, Mario Gorosito

Dermatol Pract Concept. 2017, vol7(3): 44–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661153/

■ Detection theory for accurate and non-invasive skin cancer diagnosis using dynamic thermal imaging

Sebastián E. Godoy, Majeed M. Hayat, David A. Ramirez et al

Biomed Opt Express. 2017, vol 8(4): 2301–2323

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516826/

■ Skin microtopography as a measure of photoaging and risk of squamous cell carcinoma of the skin in a US population

L.F. Kuklinski, M.S. Zens, A.E. Perry, A.C. Green, M.R. Karagas

Photodermatol Photoimmunol Photomed. 2017, vol 33(1): 41–48

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408582/

■ Mobile teledermatology for skin cancer screening: a diagnostic accuracy study

Stefan Markun, Nathalie Scherz, Thomas Rosemann, Ryan Tandjung, Ralph P. Braun

Medicine (Baltimore) 2017, vol 96(10): e6278

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348191/

■ Perceptions of risk of developing skin cancer for diverse audiences: enhancing relevance of sun protection to reduce the risk

June K. Robinson, John Friedewald, Elisa J. Gordon

J Cancer Educ. 2016 Mar; 31(1): 153–157

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881419/

■ Skin metastases in ovarian clear cell adenocarcinoma: a case report and a review of the literature

Nam G, Lim YM, Cho MS, Lee J, Kim YH.

Obstet Gynecol Sci. 2017 Nov;60(6):593-5

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571707/

■ Study of factors affecting the incidence of skin cancer in patients after liver transplant

Campos, Gabriela Rached et al.

An. Bras. Dermatol., Aug 2017, vol.92, no.4, p.492-498

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000400492&lng=pt&nrm=iso

■ Molecular basis of basal cell carcinoma.

Montagna, Erik and Lopes, Otávio Sérgio

An. Bras. Dermatol., Aug 2017, vol.92, no.4, p.517-520

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000400517&lng=pt&nrm=iso

■ Histopathological diagnosis of small melanocytic lesions suspicious for malignant melanoma

Quintella, Danielle Carvalho et al.

An. Bras. Dermatol., June 2017, vol.92, no.3, p.375-37

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300375&lng=pt&nrm=iso

■ Evaluation of surgical margins according to the histological type of basal cell carcinoma

Godoy, Charles Antonio Pires de et al.

An. Bras. Dermatol., Mar 2017, vol.92, no.2, p.226-230

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000200226&lng=pt&nrm=iso

■ Cáncer de piel en pacientes menores de 40 años

E C Martínez-Guerra, M E Sánchez-Uriarte, A Media-Bojórquez et al

Dermatologia Revista Mexicana 2017, vol 1

http://www.medigraphic.com/pdfs/derrevmex/rmd-2017/rmd171b.pdf

■ La utilidad de la técnica de citologia como método inicial diagnóstico de neoplasias epiteliales malignas de la piel

Z F Barragán-Estudillo, N Pulido-Díaz, M J Quintal-Ramíres

Dermatologia Revista Mexicana 2017, vol 2

http://www.medigraphic.com/pdfs/derrevmex/rmd-2017/rmd172c.pdf

■ Cáncer de mama con metástasis cutânea

N Porras-Kusmanic, F Norris-Squirrel

Dermatologia Revista Mexicana 2017, vol 2

http://www.medigraphic.com/pdfs/derrevmex/rmd-2017/rmd172i.pdf

■ Carcinoma basocelular metastásico. Experiencia de três casos tratados com cirurgia de Mohs

A R Gonzalez, A M Londoño, M E Meilá et al

Dermatologia Revista Mexicana 2017, vol 4

http://www.medigraphic.com/pdfs/derrevmex/rmd-2016/rmd164k.pdf

■ Comparison of the incidence of skin cancers in patients on dialysis and after kidney transplantation

Joanna Sułowicz, Anna Wojas-Pelc, Ewa Ignacak et al

Postepy Dermatol Alergol. 2017 Apr; 34(2): 138–142

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420606/

■ A matching-adjusted indirect comparison of sonidegib and vismodegib in advanced basal cell carcinoma

Dawn Odom, Deirdre Mladsi, Molly Purser et al

J Skin Cancer. 2017; 2017: 6121760.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457749/

■ . Initial basal cell carcinomas diagnosed in the National Campaign for Skin Cancer Prevention are smaller than those identified by the conventional medical referral system

Wakiyama, Thweicyka Pinheiro et a

An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.26-2

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100026&lng=pt&nrm=iso

■ Analysis of the histomorphologic profile of invasive cutaneous squamous cell carcinoma from 2002 to 2011 in a pathology laboratory in the region of Campos Gerais, Brazil

Souza, Fernanda Magri de, Baroni, Eloina Do Rocio Valenga and Montemór Netto, Mário Rodrigues

An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.81-85

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100081&lng=pt&nrm=iso

■ CD30-positive cutaneous lymphoma: report of four cases with an emphasis on clinicopathological correlations.

Vargas, Thiago Jeunon de Sousa, Jorge, Samira Barroso and Gonzaga, Yung Bruno de Mello

An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.86-91

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100086&lng=pt&nrm=iso

■ A review of the global guidelines on surgical margins for nonmelanoma skin cancers

Amanda F. Nahhas, Chase A. Scarbrough, Shannon Trotter

J Clin Aesthet Dermatol. 2017, vol 10(4): 37–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404779/

■ Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery

Fontecilla NM, Kittler NW, Geskin L, Samie FH et al

JAAD Case Rep. 2017 Sep 23;3(6):467-46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614636/

■ Secretory carcinoma of the skin: case report and review of the literature

Robert F. Moore, Jonathan D. Cuda

JAAD Case Rep. 2017 Nov; 3(6): 559–562

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683746/

■ Radiation-induced inflammatory dermatosis: another facet of the immunocompromised cutaneous district

Roger Haber, Hervé Bachelez

JAAD Case Rep. 2017 Nov; 3(6): 572–573

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684424/

■ Treatment of cutaneous leiomyomas with %% lidocaine patches ina patient with hereditary leiomyomatosis and renal cell cancer (Reed syndrome)

Tina Hsu, Lynn A. Cornelius, Ilana S. Rosman, Kathleen M. Nemer

JAAD Case Rep. 2017 Sep; 3(5): 407–409

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581856/

■ Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development

Muneeb Ilyas, Collin M. Costello, Amit Sharma

JAAD Case Rep. 2017 Jul; 3(4): 364–366

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524300/

■ Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins

Nathan M. Johnson, Alex C. Holliday, David T. Luyimbazi, et al

JAAD Case Rep. 2017 May; 3(3): 222–224

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394203/

■ Basal cell carcinoma: 10-year experience with electrochemotherapy

Luca G. Campana, Roberto Marconato, Sara Valpione et AL

J Transl Med. 2017; vol 15: 122.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452531/

■ Diagnostic accuracy of confocal microscopy imaging vs.punch biopsy for diagnosing and subtyping basal cell carcinoma

D.J. Kadouch, M.M. Leeflang, Y.S. Elshot et al

J Eur Acad Dermatol Venereol. 2017, vol 31(10): 1641–1648

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697654/

■ Public primary secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey

S Seité, V del Marmol, D Moyal, A J Friedman

Journal of the European Academy of Dermatology and Venereology 2017, vol 31 (5): 815-820

http://onlinelibrary.wiley.com/doi/10.1111/jdv.14104/full

■ The clinical and histopathological characteristics of early-onset basal cell carcinoma in Asians

M Y Yang, J M Kim, G W Kim et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 31 (1): 75-80

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13793/full

■ Skin câncer risk in outdoor workers: a European multicenter case-control study

M Trakatelli, K Barkitzi, C Apap et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 5-11

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13603/full

■ The experience of a tertiary centre in Romania on basal cell carcinomas in outdoor workers: Why to assess?

C M Salavastru, C Ulrich, S Cretu et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 12-16

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13604/full

■ Famers develop more aggressive histologic subtypes of basal cell carcinoma. Experience from a Tertiary Hospital in Northern Greece

Z Apalla, A Lallas, E Sotirou et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 117-20

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13605/full

■ Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers

A Modenese, F Farnetani, A Andreoli et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 21-26

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13606/full

■ An approximation of occupational lifetime UVR exposure: algorithm for retrospective assessment and current measurements

M Wittlich, S Westerhausen, P Kleinespel et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 21-33

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13607/full

■ Knowlwdge of outdoor worker on the effects of natural UV radiation and methods of protection against exposure

K Hault, H Rönsch, S Beissert et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 34-37

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13631/full

■ Consensus Report: Recognizing non-melanoma skin cancer, incluind actinic keratosis, as an occupational disease – A Call for Action

S M John, M Trakatelli, R Gehring et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 38-45

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13608/full

■ The European Status Quo in legal recognition and patient-care services of occupational skin cancer

C Ulrich, S Salavastru, T Agner et al

Journal of the European Academy of Dermatology and Venereology 2017, vol 30 (S3): 46-51

8-45

http://onlinelibrary.wiley.com/doi/10.1111/jdv.13609/full

■ Indication guidelines for Mohs micrographic surgery in skin tumors

Cernea, Selma Schuartz et al.

An. Bras. Dermatol., Oct 2016, vol.91, no.5, p.621-627

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000500621&lng=pt&nrm=iso

■ Cutaneous metastasis as the first manifestation of occult malignant breast neoplasia

Weimann, Ellem Tatiani de Souza et al.

An. Bras. Dermatol., Oct 2016, vol.91, no.5, suppl.1, p.105-107.

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100105&lng=pt&nrm=iso

■ Expression of heparanase in basal cell carcinoma and squamous cell carcinoma

Pinhal, Maria Aparecida Silva et al.

An. Bras. Dermatol., Oct 2016, vol.91, no.5, p.595-60

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000500595&lng=pt&nrm=iso

■ Non-melanoma skin cancer in Portuguese kidney transplant recipients – incidence and risk factors

Pinho, André et al.

An. Bras. Dermatol., Aug 2016, vol.91, no.4, p.455-462

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000400455&lng=pt&nrm=iso

■ Responsiveness of the Spanish version of the ¨skin cancer index¨

M de Troya-Martin, F Rivas-Ruiz, N Blásquez-Sánchez et al

Journal of Skin Cancer2016 (2016), Article ID 8180348, 4 pages

https://www.hindawi.com/journals/jsc/2016/8180348/

■ Inflammatory bowel disease and skin cancer: an assessment of patient risk factors, knowledge, and skin practices

J N Kimmel, t H Taft, L Keefer

Journal of Skin Cancer2016 (2016), Article ID 4632037, 7 pages

https://www.hindawi.com/journals/jsc/2016/4632037/

■ Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features

Bernardes Filho, Fred et al.

An. Bras. Dermatol., Feb 2016, vol.91, no.1, p.73-79

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000100073&lng=pt&nrm=iso

■ Skin cancer surveillance behaviors among childhood cancer survivors

Jerod L. Stapleton, Kristina L. Tatum, Katie A. Devine et al

Pediatr Blood Cancer. 2016, vol 63(3): 554–557

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724328/

■ A clinical aid for detecting skin cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA)

Rogers, M. L. Marino, S. W. Dusza et al

J Am Board Fam Med. 2016 Nov-Dec; 29(6): 694–701.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536949/

■ Ultraviolet radiation exposure and its impacto n skin câncer risk

Meg Watson, Dawn M. Holman, Maryellen Maguire-Eisen

Semin Oncol Nurs. 2016 Aug; 32(3): 241–254

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036351/

■ Sepctroscopic and imaging characteristics of pigmented non-melanoma skin câncer and melanoma in patients with skin phototypes III and IV

Stefanie Arroyo-Camarena, Judith Domínguez-Cherit, Lorena Lammoglia-Ordiales et al

Oncol Ther. 2016; 4(2): 315–331

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315082/

■ Dermal substitutes use in reconstructive surgey for skin tumors: a single-center experience

Mariane Campagnari, Andrea S. Jafelicci, Helio A. Carneiro, Eduard R. Brechtbühl, Eduardo Bertolli, João P. Duprat Neto

Int J Surg Oncol. 2017; 2017: 980598

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511644/

■ An update on Kaposi´s sarcom: epidemiology, pathogenesis and treatment

Paul Curtiss, Lauren C. Strazzulla, Alvin E. Friedman-Kien

Dermatol Ther (Heidelb) 2016 Dec; 6(4): 465–470

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120640/

■ Cutaneous human papillomavirus infection and development of subsequent squamous cell carcinoma of the ski

Shalaka S. Hampras, Rhianna A. Reed, Spencer Bezalel et al

J Skin Cancer. 2016; 2016: 1368103

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116506/

■ Pruritus reduction with systemic anti-lymphoma treatments in patients with cutaneous T Cell lymphoma: a narrative review

Halle Field, Ling Gao, Pooja Motwani, Henry K. Wong

Dermatol Ther (Heidelb) 2016 Dec; 6(4): 579–595

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120632/

■ Acute and chronic cutaneous reactions to ionizing radiation therapy

Fleta N. Bray, Brian J. Simmons, Aaron H. Wolfson, Keyvan Nouri

Dermatol Ther (Heidelb) 2016 Jun; 6(2): 185–206

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906114/

■ Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.

Cabete, Joana et al.

An. Bras. Dermatol., Dec 2015, vol.90, no.6, p.846-85

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000600846&lng=pt&nrm=iso

■ A importância da atuação do médico do trabalho na prevenção do câncer de pele ocupacional

C A Pereira

Revista Brasileira de Medicina do Trabalho 2015

http://www.rbmt.org.br/details/215/pt-BR/a-importancia-da-atuacao-do-medico-do-trabalho-na-prevencao-do-cancer-de-pele-ocupacional

■ Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective

J T Lear, C Corner, P Dziewulsk et al

British Journal of Cancer 2014, vol 111: 1476-1481

https://www.nature.com/articles/bjc2014270

■ Measuring current and future cost ofskin cancer in England

L Vallejo-Torres, S Morris, J M Kinge et al

Journal of Public Health2014, vol 36 (1): 140-148

https://academic.oup.com/jpubhealth/article/36/1/140/1570379

■ Diagnosis and treatment of basal cell and squamous cell carcinoma

J M Firnhaber

Am Fam Physician 2012, vol 86 (2): 161-168

http://www.aafp.org/afp/2012/0715/p161.html

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306 / 40204020

CRMMG: 7026

Email: pfleite1873@gmail.com